Cardiomyopathy Awareness 2024
Think Cardiomyopathy

Cardiomyopathy Awareness 2024
Think Cardiomyopathy

Cardiomyopathy Awareness

Cardiomyopathy affects around 1 in every 250 people worldwide. It is a disease of the heart muscle that can occur at any age and can be passed down genetically. Often underdiagnosed, misdiagnosed, or diagnosed too late, the consequences of cardiomyopathy can be very serious. If untreated, cardiomyopathy can weaken the heart, leading complications and to more serious conditions.

Follow the campaign using: #ThinkCardiomyopathy | #CardiomyopathyAwareness | #Cardiomyopathy2024 | #ThinkCM

Share This Message!

Ruth’s Story

Ruth’s daughter, Judith, died suddenly in 2011 at 14 years old from sudden cardiac death as a result of undiagnosed cardiomyopathy.

Cardiomyopathy is a disease of the heart muscle that can occur at any age and can be passed down genetically. It is a predominant cause of sudden cardiac death in people under the age of 35.

Following genetic testing and investigations, Ruth discovered that both her husband and son were gene positive for the same cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy (ARVC).

It’s time to take notice of cardiomyopathy. You or a loved one could unknowingly be at risk. Think Cardiomyopathy. Watch Ruth’s video to learn more.

German

Spanish

Swedish

Aistė’s Story

Did you know that cardiomyopathy is an important cause of heart failure and the leading reason for needing a heart transplant? Watch now to hear Aistė’s story.

Aistė Štaraitė, from Lithuania, was diagnosed with life-changing, end-stage heart failure before her 30th birthday. Tests revealed that Aistė was living with undiagnosed dilated cardiomyopathy, the most common type of cardiomyopathy which causes the muscle of the heart chambers to become weakened and enlarged.

A heart failure and cardiomyopathy survivor, Aistė shares her story and her message to “Think Cardiomyopathy”.

#ThinkCardiomyopathy | #CardiomyopathyAwareness | #Cardiomyopathy2024 | #ThinkCM

Share This Message!

German

Spanish

Michael’s Story 

Cardiomyopathy is a disease of the heart muscle that is often underdiagnosed, misdiagnosed or diagnosed too late.
Michael, from Melbourne, Australia, was misdiagnosed for over 20 years. Watch now to hear his story.

#ThinkCardiomyopathy | #CardiomyopathyAwareness | #Cardiomyopathy2024 | #ThinkCM

Share This Message!

German

Hannah’s Story

Hannah experienced subtle symptoms of cardiomyopathy at a young age – including fainting and heart palpitations – but didn’t think much of it until her aunt was diagnosed with cardiomyopathy.
Hannah visited a cardiologist who diagnosed her with hypertrophic cardiomyopathy (HCM) – the most common inherited cardiomyopathy. Given the condition her heart was in, her cardiologist was surprised she hadn’t already had a sudden cardiac arrest and suggested an implantable cardioverter defibrillator (ICD), which saved her life one year later when she went into sudden cardiac arrest in her sleep.

It’s time to take notice of cardiomyopathy. You or a loved one could unknowingly be at risk. Think Cardiomyopathy. Watch now to hear her story.

#ThinkCardiomyopathy | #CardiomyopathyAwareness | #Cardiomyopathy2024 | #ThinkCM

Share This Message!

Spanish

German

Stay tuned for more videos coming soon!

Think Cardiomyopathy! … and think fast!

Cardiomyopathy is often underdiagnosed, misdiagnosed, or diagnosed too late, and the consequences can be very serious. If untreated, cardiomyopathy can weaken the heart, leading to complications and to more serious conditions.

Cardiomyopathy is a predominant cause of sudden cardiac death in individuals under 35. It is an important cause of heart failure and the leading reason for needing a heart transplant.

Cardiomyopathy Awareness 2024
Cardiomyopathy Awareness 2024

Think Cardiomyopathy! Understand your family’s heart health.

Knowing if you have an inherited type of cardiomyopathy is important because it can impact the risk for other family members. Inherited cardiomyopathy is the most common form of genetic heart disease.

Paying attention to symptoms, knowing your family history, and seeking care could be lifesaving.

Cardiomyopathy Awareness 2024

Think Cardiomyopathy! Understand the symptoms:

  • irregular or rapid heartbeat
  • tiredness / breathlessness
  • dizziness / fainting
  • chest pain / heaviness
  • swollen stomach, legs, ankles or feet
  • no symptoms

Signs and symptoms of cardiomyopathy can vary widely. In its earliest stages cardiomyopathy may not have symptoms or symptoms may be mild.

One out of eight people over the age of 75 suffers from moderate to severe heart valve disease, which involves damage to one or more of the heart’s valves. It is estimated that the number of people living with heart valve disease will double by 2040 and triple by 2060.

Heart Valve Disease prevalence is rising rapidly due to the ageing of the population. People are living longer and older people are crucial contributors to society and the economy. Untreated valve disease is a barrier to active ageing but conversely, early detection and timely treatment will increase longevity and quality of life.

Often heart valve disease patients are diagnosed only when they see a healthcare professional for a regular check-up or for some other issue. The seriousness of heart valve disease, combined with the fact that the symptoms are often difficult to detect or dismissed as a normal part of ageing, can often result in troublesome or dangerous consequences.

Think Cardiomyopathy
Think Cardiomyopathy

Think Cardiomyopathy!
Talk to your doctor.

Talk to your doctor if you notice any symptoms or have a family history of heart disease or sudden cardiac death. There is no cure for cardiomyopathy, but treatment and lifestyle changes can help control symptoms, and prevent progression and serious complications.

Types of Cardiomyopathy:

There are various types of cardiomyopathy, each with unique characteristics and potential impacts on health. The three main types of cardiomyopathy are:

  • Dilated cardiomyopathy (DCM) – the most common type of cardiomyopathy; is inherited in up to 40% of cases; causes the muscle of the heart chambers (ventricles) to become weakened and enlarged.
  • Hypertrophic cardiomyopathy (HCM) – the most common inherited cardiomyopathy; characterized by the thickening of the main pumping chamber of the heart (the left ventricle); the left ventricle generally becomes stiffer over time and less capable of taking in or pumping out blood.
  • Arrhythmogenic cardiomyopathy (ACM) / Arrhythmogenic right ventricular cardiomyopathy (ARVC)] – an inherited form of cardiomyopathy that is characterized by progressive replacement of the heart muscle with scar tissue, causing heart rhythm irregularities (arrhythmias).

Other less common types include:

  • Cardiac amyloidosis – a form of restrictive cardiomyopathy caused by the build-up of amyloid protein deposits in the heart muscle.
  • Restrictive cardiomyopathy (RCM) – an uncommon form of cardiomyopathy that is characterized by stiffening of the heart’s lower chambers (ventricles).
  • Peripartum cardiomyopathy (PPCM) – a rare form of dilated cardiomyopathy that occurs towards the end of pregnancy or in the months following delivery.

French

Italian

Spanish

Polish

Portuguese (Brazil)

Romanian

Swedish

Think Cardiomyopathy

About this campaign

Led by the GHH’s Cardiomyopathy Patient Council which now spans 24 patient organisations across 15 countries, the campaign this year focuses on patient and advocate stories on the impact of cardiomyopathy and the importance of recognising symptoms and knowing your family history.

The Cardiomyopathy Patient Council was formed in November 2021 and brings together patient organisations across the world to increase awareness and understanding of cardiomyopathy. The Patient Council advocates for improved diagnosis of the condition, access to appropriate testing, counselling and treatments. In addition, the Council aims to raise awareness and improve understanding of the disease, with a view to enabling people to live well with the condition.

The Patient Council’s mission is to identify and bring together cardiomyopathy-focussed and patient- led organisations across the world, creating a global alliance and common patient voice that raises awareness and improves diagnosis, management and understanding of cardiomyopathy for patients, caregivers and healthcare providers to ensure the best possible outcomes for those living with the disease.

CMAA_Logo
Defibbers Cymru logo
HeartCharged Corporation Logo
Hypertrofisk Kardiomyopatis Svenska Sällskap
Heart Health India Foundation
ICDefibrillators
In A Heartbeat - Logo
Sads-logo-revised

Get Involved

To join the campaign or for more information, please email info@globalhearthub.org.

Supported by